STOCK TITAN
  1. Home
  2. Sec-filings
  3. DK
  4. [Form 4] Delek US Holdings, Inc. Insider Trading Activity

Delek US (NYSE: DK) director sells 34K shares via Rule 10b5-1 plan

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Delek US Holdings director Ezra Uzi Yemin reported an open-market sale of 34,026 shares of common stock on May 4, 2026, at a weighted average price of $47.29 per share. The shares were sold indirectly through Yemin Investments, LP pursuant to a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Yemin holds 447,795 shares indirectly through Yemin Investments, LP and 210,281 shares directly.

Positive

  • None.

Negative

  • None.
Insider Yemin Ezra Uzi
Role null
Sold 34,026 shs ($1.61M)
Type Security Shares Price Value
Sale Common Stock 34,026 $47.29 $1.61M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 447,795 shares (Indirect, By Yemin Investments, LP); Common Stock — 210,281 shares (Direct, null)
Footnotes (1)
  1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $47.00 per share to a high sale price of $47.93 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Shares sold 34,026 shares Open-market sale of common stock on May 4, 2026
Weighted average sale price $47.29 per share Aggregate price for multiple trades in the reported sale
Price range of trades $47.00–$47.93 per share Lowest and highest sale prices within the reported transaction
Indirect holdings after transaction 447,795 shares Common stock held by Yemin Investments, LP after sale
Direct holdings after transaction 210,281 shares Common stock held directly by Ezra Uzi Yemin
Net shares sold 34,026 shares Net sell direction based on transaction summary
Rule 10b5-1 regulatory
"This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
10b5-1 plan regulatory
"This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."
A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.
affirmative defense regulatory
"This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."
weighted average sale price financial
"The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $47.00 per share to a high sale price of $47.93 per share."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Yemin Ezra Uzi
(Last)(First)(Middle)
310 SEVEN SPRINGS WAY
SUITE 500
(Street)
BRENTWOOD TENNESSEE 37027
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/04/2026S34,026(1)D$47.29(2)447,795IBy Yemin Investments, LP
Common Stock210,281D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
2. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $47.00 per share to a high sale price of $47.93 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Remarks:
/s/ Ezra Uzi Yemin05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Delek US (DK) report for Ezra Uzi Yemin?

Delek US reported that director Ezra Uzi Yemin indirectly sold 34,026 shares of common stock. The sale occurred on May 4, 2026, through Yemin Investments, LP at a weighted average price of $47.29 per share, as disclosed in a Form 4 filing.

At what price were the Delek US (DK) shares sold in the latest Form 4?

The reported transaction used a weighted average sale price of $47.29 per Delek US share. Actual trades ranged from $47.00 to $47.93 per share, with multiple executions combined. The filing notes the insider can provide exact share counts at each price upon written request.

Was the recent Delek US (DK) insider sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan. Such plans are pre-arranged trading programs designed to satisfy the affirmative defense conditions of Rule 10b5-1(c), reducing the significance of trade timing interpretations.

How many Delek US (DK) shares does Ezra Uzi Yemin hold after the sale?

After the reported sale, Ezra Uzi Yemin holds 447,795 Delek US common shares indirectly through Yemin Investments, LP. He also holds 210,281 shares directly. These post-transaction holdings are disclosed in the Form 4 as total shares following the transaction.

Is the Delek US (DK) insider transaction a direct or indirect holding change?

The 34,026-share sale involved an indirect holding, executed by Yemin Investments, LP. The Form 4 identifies this position as indirect ownership, while a separate entry shows 210,281 shares held directly by Ezra Uzi Yemin with no buy or sell activity reported in that line.